Wangxiong Hu
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 6
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 7
- Colorectal Cancer Treatments and Studies 6
-
- Epigenetics and DNA Methylation 6
- RNA modifications and cancer 5
- Pathology and Forensic Medicine top 10%
- Genetic factors in colorectal cancer 11
-
- Immunotherapy and Immune Responses 5
-
- Ferroptosis and cancer prognosis 7
- Journals
- Biochemical and Biophysical Research Communications (3 papers)International Journal of Cancer (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Wangxiong Hu
41 papers receiving 980 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 349
- Oncology 327
- Molecular Biology 562
- Pathology and Forensic Medicine 132
- Immunology 131
Countries citing papers authored by Wangxiong Hu
This map shows the geographic impact of Wangxiong Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangxiong Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangxiong Hu more than expected).
Fields of papers citing papers by Wangxiong Hu
This network shows the impact of papers produced by Wangxiong Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangxiong Hu. The network helps show where Wangxiong Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wangxiong Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 14 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 5 | |
| 7 | 2021 | 24 | |
| 8 | 2021 | 13 | |
| 9 | 2021 | 12 | |
| 10 | 2020 | 3 | |
| 11 | 2020 | 39 | |
| 12 | 2019 | 40 | |
| 13 | 2019 | 1 | |
| 14 | 2019 | 15 | |
| 15 | 2019 | 38 | |
| 16 | 2018 | 40 | |
| 17 | 2017 | 26 | |
| 18 | 2015 | 81 | |
| 19 | 2014 | 3 | |
| 20 | 2012 | 10 |
About Wangxiong Hu
Wangxiong Hu is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 45 papers that have together received 986 indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (11 papers), Ferroptosis and cancer prognosis (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Cancer-related molecular mechanisms research (6 papers), Epigenetics and DNA Methylation (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Immunotherapy and Immune Responses (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Cancer Research (349 citations), Oncology (327 citations) and Molecular Biology (562 citations). Wangxiong Hu has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Shu Zheng, Yanmei Yang, Lina Qi, Weiting Ge, Chenyang Ye, Jian‐Hong Xu, Jiani Chen, Ying Yuan, Kailun Xu and Tingzhang Wang. Their work appears in journals such as Biochemical and Biophysical Research Communications, International Journal of Cancer and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.